Comparative effectiveness and safety of inhaled corticosteroid plus long-acting β < sub > 2 < /sub > -agonist fixed-dose combinations vs. long-acting muscarinic antagonist in bronchiectasis

CONCLUSION: Our findings provide important evidence on the effectiveness and safety of ICS/LABA FDC compared with LAMA for bronchiectasis. BEC/FOR and BUD/FOR were associated with better outcomes than FLU/SAL.PMID:38224017 | DOI:10.1080/17512433.2024.2306218
Source: Expert Review of Clinical Pharmacology - Category: Drugs & Pharmacology Authors: Source Type: research